In last trading session, 10x Genomics Inc (NASDAQ:TXG) saw 6.48 million shares changing hands with its beta currently measuring 2.00. Company’s recent per share price level of $11.66 trading at $0.77 or 7.07% at ring of the bell on the day assigns it a market valuation of $1.46B. That closing price of TXG’s stock is at a discount of -112.35% from its 52-week high price of $24.76 and is indicating a premium of 41.85% from its 52-week low price of $6.78.
For 10x Genomics Inc (TXG), analysts’ consensus is at an average recommendation of Hold while assigning it a mean rating of 2.26. Splitting up the data highlights that, out of 8 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 5 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
10x Genomics Inc (NASDAQ:TXG) trade information
Upright in the green during last session for gaining 7.07%, in the last five days TXG remained trading in the green while hitting it’s week-highest on Wednesday, 06/25/25 when the stock touched $11.66 price level, adding 3.08% to its value on the day. 10x Genomics Inc’s shares saw a change of -40.63% in year-to-date performance and have moved 10.42% in past 5-day. 10x Genomics Inc (NASDAQ:TXG) showed a performance of 42.72% in past 30-days.
Wall Street analysts have assigned a consensus price target of 25 to the stock, which implies a rise of 53.36% to its current value. Analysts have been projecting 24 as a low price target for the stock while placing it at a high target of 46. It follows that stock’s current price would drop -105.83% in reaching the projected high whereas dropping to the targeted low would mean a loss of -105.83% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -36.10% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 20.25% while estimates for its earnings growth in next 5 years are of 24.87%.
10x Genomics Inc (NASDAQ:TXG)’s Major holders
FMR LLC is the top institutional holder at TXG for having 13.01 million shares of worth $253.05 million. And as of 2024-06-30, it was holding 10.836 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 10.19 million shares on 2024-06-30. The number of shares represents firm’s hold over 8.4863 of outstanding shares, having a total worth of $198.18 million.
